Effects of long and short hemodialysis on endothelial function: A short-term study

Kidney International

Volumn 63, Issue 2, 2003, Pages 709-715

  McGregor, David O ^a   Buttimore, Adrian L ^a   Lynn, Kelvin L ^a   Yandle, Timothy ^a   Nicholls, M Gary ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Adrenomedullin; Atrial natriuretic peptide; End stage renal disease; Endothelium; Hypertension; Nitric oxide

Indexed keywords

ADRENOMEDULLIN; ANTIHYPERTENSIVE AGENT; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; GLYCERYL TRINITRATE; HOMOCYSTEINE; NATRIURETIC PEPTIDE TYPE C; NEUROHORMONE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BLOOD PUMP; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENDOTHELIUM CELL; FEMALE; HEMODIALYSIS; HORMONE SYNTHESIS; HUMAN; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR DISEASE; VASODILATATION;

EID: 0037249703     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00770.x     Document Type: Article

References (45)

1. HALLER H: Endothelial function. General considerations. Drugs 53(Suppl):1-10, 1997
2. HULTBERG B, ANDERSSON A, STERNER G: Plasma homocysteine in renal failure. Clin Nephrol 40:230-235, 1993
3. LAZARUS JM, LOWRIE EG, HAMPERS CL, MERRILL JP: Cardiovascular disease in uremic patients on hemodialysis. Kidney Int 7(Suppl 2):S167-S175, 1975
4. VALLANCE P, LEONE A, CALVER A, et al: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572-575, 1992
5. VANHOUTTE PM: The endothelium-modulator of vascular smooth-muscle tone. N Engl J Med 319:512-513, 1988
6. PLAYFORD DA, WATTS GF: Special article: non-invasive measurement of endothelial function. Clin Exp Pharmacol Physiol 25:640-643, 1998
7. CHIN-DUSTING JP, CAMERON JD, DART AM, JENNINGS GL: Human forearm venous occlusion plethysmography: Methodology, presentation and analysis. Clin Sci Colch 96:439-440, 1999
8. LIP GY, BLANN A: von Willebrand factor: A marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 34:255-265, 1997
9. VAN GULDENER C, LAMBERT J, JANSSEN MJ, et al: Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant 12(Suppl 2):14-18, 1997
10. VAN GULDENER C, JANSSEN MJ, LAMBERT J, et al: Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 13:1782-1786, 1998
11. CHARRA B, CALEMARD M, LAURENT G: Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 16:35-44, 1996
12. LUIK AJ, KOOMAN JP, LEUNISSEN KM: Hypertension in haemodialysis patients: is it only hypervolaemia? Nephrol Dial Transplant 12:1557-1560, 1997
13. SHAND BI, SCOTT RS, FLORKOWSKI CM, et al: A comparison of post-prandial changes in flow-mediated dilatation in patients with type 2 diabetes with and without macroalbuminuria. Diabetes Nutr Metab 14:201-206, 2001
14. CROSS JM, DONALD A, VALLANCE PJ, et al: Dialysis improves endothelial function in humans. Nephrol Dial Transplant 16:1823-1829, 2001
15. SAX FL, CANNON RO, HANSON C, EPSTEIN SE: Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function? N Engl J Med 317:1366-1370, 1987
16. KUSHNER RF, SCHOELLER DA: Estimation of total body water by bioelectrical impedance analysis. Am J Clin Nutr 44:417-424, 1986
17. DAUGIRDAS JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 4:1205-1213, 1993
18. HARKNESS J: The viscosity of human plasma, its measurement in health and disease. Biorheology 8:171-193, 1971
19. SHORT PE, WILLIAMS CE, PICKEN AM, HILL FG: Factor VIII related antigen: An improved enzyme immunoassay. Med Lab Sci 39:351-355, 1982
20. LAINCHBURY JG, NICHOLLS MG, ESPINER EA, et al: Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure. Hypertension 34:70-75, 1999
21. HUNT PJ, RICHARDS AM, NICHOLLS MG, et al: Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment. Clin Endocrinol (Oxf) 47:287-296, 1997
22. LEWIS LK, SMITH MW, YANDLE TG, et al: Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: Plasma concentration, adsorption, and storage. Clin Chem 44:571-577, 1998
23. KITAMURA K, TANAKA T, KATO J, et al: Regional distribution of immunoreactive endothelin in porcine tissue: Abundance in inner medulla of kidney. Biochem Biophys Res Commun 161:348-352, 1989
24. MIYAZAKI H, MATSUOKA H, ITABE H, et al: Hemodialysis impairs endothelial function via oxidative stress: Effects of vitamin E-coated dialyzer. Circulation 101:1002-1006, 2001
25. KOSCH M, LEVERS A, BARENBROCK M, et al: Acute effects of haemodialysis on endothelial function and large artery elasticity. Nephrol Dial Transplant 16:1663-1668, 2001
26. HAND MF, HAYNES WG, WEBB DJ: Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int 53:1068-1077, 1998
27. VALLANCE P, LEONE A, CALVER A, et al: Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 20(Suppl 12):S60-2:S60-S62, 1992
28. MACALLISTER RJ, RAMBAUSEK MH, VALLANCE P, et al: Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant 11:2449-2452, 1996
29. ARESE M, STRASLY M, RUVA C, et al: Regulation of nitric oxide synthesis in uraemia. Nephrol Dial Transplant 10:1386-1397, 1995
30. SHICHIRI M, HIRATA Y, ANDO K, et al: Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 15:493-496, 1990
31. KITAMURA K, KANGAWA K, KAWAMOTO M, et al: Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553-560, 1993
32. HAYNES WG, WEBB DJ: Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344:852-854, 1994
33. MAJID DS, KADOWITZ PJ, COY DH, NAVAR LG: Renal responses to intra-arterial administration of adrenomedullin in dogs. Am J Physiol 270:F200-F205, 1996
34. SURDACKI A, SULOWICZ W, WIECZOREK-SURDACKA E, HERMAN ZS: Effect of a hemodialysis session on plasma levels of endothelin-1 in hypertensive and normotensive subjects with end-stage renal failure. Nephron 81:31-36, 1999
35. NOYAN A, ANARAT A, ANARAT R, NOYAN T: Acute changes in endothelin after hemodialysis in children. Pediatr Nephrol 12:153-156, 1998
36. MALLAMACI F, ZOCCALI C, PARLONGO S, et al: Plasma adrenomedullin during acute changes in intravascular volume in hemodialysis patients. Kidney Int 54:1697-1703, 1998
37. WASHIMINE H, YAMAMOTO Y, KITAMURA K, et al: Plasma concentration of human adrenomedullin in patients on hemodialysis. Clin Nephrol 44:389-393, 1995
38. TOTSUNE K, TAKAHASHI K, MURAKAMI O, et al: Elevated plasma C-type natriuretic peptide concentrations in patients with chronic renal failure. Clin Sci Colch 87:319-322, 1994
39. TAKAHASHI M, NAGAKE Y, ICHIKAWA H, et al: Plasma concentrations of natriuretic peptides in patients on hemodialysis. Res Commun Mol Pathol Pharmacol 92:19-30, 1996
40. CHAZOT C, CHARRA B, LAURENT G, et al: Interdialysis blood pressure control by long haemodialysis sessions. Nephrol Dial Transplant 10:831-837, 1995
41. LUIK AJ, CHARRA B, KATZARSKI K, et al: Blood pressure control and hemodynamic changes in patients on long time dialysis treatment. Blood Purif 16:197-209, 1998
42. VAN TELLINGEN A, GROOTEMAN MP, BARTELS PC, et al: Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients. Kidney Int 59:342-347, 2001
43. STAMPFER MJ, VERHOEF P: Prospective studies of homocysteine and cardiovascular disease, in Homocysteine Metabolism: From Basic Science to Clinical Medicine, edited by GRAHAM I, REFSUM H, ROSENBERG IH, UELAND PM, Dordrecht, Kluwer Academic Publishers, 1997, p 239
44. HOFMANN MA, KOHL B, ZUMBACH MS, et al: Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 21:841-848, 1998
45. USUI M, MATSUOKA H, MIYAZAKI H, et al: Endothelial dysfunction by acute hyperhomocyst(e)inaemia: Restoration by folic acid. Clin Sci Colch 96:235-239, 1999